Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes - Wikidata - awgldk - TriplyDB

Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes

Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes

http://www.wikidata.org/entity/Q28750802

about

sameAs

Induced Pluripotent Stem Cell as a New Source for Cancer Immunotherapy Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease Modeling Induced Pluripotent Stem Cells as a Novel Tool in Psychiatric Research Induced Pluripotent Stem Cells and Periodontal Regeneration In Vitro T-Cell Generation From Adult, Embryonic, and Induced Pluripotent Stem Cells: Many Roads to One Destination Induced pluripotent stem cells as a disease modeling and drug screening platform Modeling neurological disorders by human induced pluripotent stem cells Stem cell sources for vascular tissue engineering and regeneration Generation of highly purified human cardiomyocytes from peripheral blood mononuclear cell-derived induced pluripotent stem cells A robust strategy for negative selection of Cre-loxP recombination-based excision of transgenes in induced pluripotent stem cells Generation and characterization of functional cardiomyocytes derived from human T cell-derived induced pluripotent stem cells CD44 is a negative cell surface marker for pluripotent stem cell identification during human fibroblast reprogramming Advances and Challenges on Cancer Cells Reprogramming Using Induced Pluripotent Stem Cells Technologies A defined, feeder-free, serum-free system to generate in vitro hematopoietic progenitors and differentiated blood cells from hESCs and hiPSCs Generation of induced pluripotent stem cells from CD34+ cells across blood drawn from multiple donors with non-integrating episomal vectors Genetic Correction of Induced Pluripotent Stem Cells From a Deaf Patient With MYO7A Mutation Results in Morphologic and Functional Recovery of the Derived Hair Cell-Like Cells.Derivation of transgene-free human induced pluripotent stem cells from human peripheral T cells in defined culture conditions The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications.Induced pluripotency as a potential path towards iNKT cell-mediated cancer immunotherapy.Small molecule screening in human induced pluripotent stem cell-derived terminal cell types.Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells.Human endometrial cells express elevated levels of pluripotent factors and are more amenable to reprogramming into induced pluripotent stem cells.iPS Cells for Modelling and Treatment of Retinal Diseases Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells.Human-induced pluripotent stem cells generated from intervertebral disc cells improve neurologic functions in spinal cord injury Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells.Immunological applications of stem cells in type 1 diabetes.Opportunities for use of human iPS cells in predictive toxicology Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation Hair follicle: a novel source of multipotent stem cells for tissue engineering and regenerative medicine Human iPS cell-derived hematopoietic progenitor cells induce T-cell anergy in in vitro-generated alloreactive CD8(+) T cells Adoptive Transfer of CD8+ T Cells Generated from Induced Pluripotent Stem Cells Triggers Regressions of Large Tumors Along with Immunological Memory.Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression Human pluripotent stem cell models of autism spectrum disorder: emerging frontiers, opportunities, and challenges towards neuronal networks in a dish Stem cells and their derivatives: a renaissance in cardiovascular translational research.Applications of patient-specific induced pluripotent stem cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease.Advancements in reprogramming strategies for the generation of induced pluripotent stem cells.Concise review: non-cell autonomous reprogramming: a nucleic acid-free approach to induction of pluripotency.

P2860

Q26750579-A9B0C2DA-772A-4884-AFB8-7A9933FEEDD7 Q26750618-9223608A-8B72-481E-98F0-76C1719C739B Q26772019-E5FE5613-9BF7-4DC6-BDD7-19E7A23282A4 Q26777488-0C9D1666-5F94-41B8-9C2D-713191BC8A85 Q26801403-7AE0018D-1D83-468D-9500-BA416BBA4E3F Q26865689-3D58C220-8980-4FA9-9313-02F28C5B241C Q27011777-A2198B95-A4F9-4826-92FE-130F4922B98E Q27028106-05229292-D0F7-4537-8AD9-E38D21BF221F Q27307424-2771E542-FB19-492A-B874-C5D47198ADD3 Q27318778-596E3316-941E-4778-B5BB-69B67615E5EE Q27333621-1C386896-FD3B-484D-B969-918A3915238E Q27333857-ED8A4CA0-C35A-4C43-9FC7-E96F620CA299 Q28071879-5D906A36-B69F-4B89-B774-8F38257818D3 Q28477450-2E30C2E5-5FE0-48DD-9001-4EC9C10B869B Q28742368-F8D4E374-8F4B-48B1-ADB8-E554FE456D33 Q30357879-056688ED-638D-44A9-98F8-17B52DD17668 Q31161161-EEB7CBB4-C965-4CFF-8BCB-50036B3837BF Q33748399-60B0EAAD-3DC4-44BC-9008-E5099127EE3C Q34275397-BEE3D172-25C8-4035-8575-D9C696F8F265 Q35074117-B8BD335B-14AF-4E51-AA26-760A0C97C281 Q35172462-A82BD6F7-E4CD-40BE-AE09-08AACE54311A Q35416543-C665F6E6-59A8-4585-9245-F474F9DFA395 Q35750572-BCA653BC-EF9C-43CE-AA88-65C4D5F88E15 Q35923410-992460DE-AD1F-4A88-A7F5-6C69D6F95931 Q35930059-3B784091-0ACA-4705-8DE4-E523C9A4FE8B Q36448423-0617C683-D980-450C-B144-872A72F78E59 Q36666422-D4C70A0C-E28A-4A27-8179-872DC508EB8D Q36672246-3598AEB9-1DB6-409F-9B12-A8680A563EE1 Q36827836-163B59F8-98C9-4357-9FFE-FCF6A49F57D0 Q36879075-A88EF39E-F8D2-4632-9919-D14C8305D8E7 Q36948090-A02159ED-BE77-4D20-B029-8684680E87BD Q36962670-8F992443-CFAD-4F12-A89A-7417A854A97B Q37014144-049AED5F-C6D6-4A8A-B2EC-2641FB6BA596 Q37121662-8209F64B-24F9-4CB9-B18B-45E8C13E9C7D Q37131138-17CABF99-1E48-4582-B80C-21849FE863D8 Q37598427-AE09B8CF-0B26-480C-A4A7-2D4CBCD1ABE7 Q37808135-B68CC711-7F36-4C2C-8B3A-FA827B9335C3 Q37823231-55EF714F-0FC9-48BF-9D96-C1E963E8E25A Q37850732-287255BA-7D5D-4D48-9659-3B444D27453E Q37872272-6FD58EC7-1F4C-4D65-B36B-68E9AD8A5A29

P2860

Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes

http://www.wikidata.org/entity/Q28750802

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes

@ast

Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes

@en

Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes

@nl

type

label

Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes

@ast

Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes

@en

Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes

@nl

prefLabel

Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes

@ast

Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes

@en

Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes

@nl

P1433

Q28750802-F6E79F9A-398B-4C90-BB10-300BEB6ECBCD

P1476

Q28750802-5DF996CA-62CC-4AC6-BE26-338C1E844B94

P2093

Q28750802-343AFC37-11B7-49AF-A414-A1316EB2C627

Q28750802-5833E8E7-C67F-41A5-8CDD-61225CDEEA3A

Q28750802-7451D47E-3740-4443-9769-E3CDB073FCEE

Q28750802-775C34B4-CB33-46BD-90B8-E29D37281D9A

Q28750802-8E47F03F-9640-48DB-A2DC-58A7A502D340

Q28750802-9A3CC03E-1A3E-41F4-A451-2E0DCF9AB381

Q28750802-B9C2C532-948B-4F9C-ADA8-FD9FD4B3882A

Q28750802-ED0678DB-5E05-4268-A533-5CDF07EAF37F

Q28750802-F29E2320-659C-4D5A-9526-FC274EA7B493

P2860

Q28750802-03D86606-1985-433C-A4B2-8507EDD152C8

Q28750802-0CE746F1-804F-458C-935E-EE5EE7F079E2

Q28750802-0E06E1D6-19DA-4112-A561-5A08E7D73314

Q28750802-11D149CC-2116-411F-A847-E268D0096D3D

Q28750802-1A2E8C6D-90DB-4EEB-8629-9A0FF9342274

Q28750802-24B33630-19CA-4D9C-9EF0-5A3ECEAB2619

Q28750802-2D8F3920-B516-4476-A8AC-32C4182CEE43

Q28750802-3AC38E78-5B45-4B52-8376-52457969BBFD

Q28750802-3F79227D-19AA-4B89-B0A9-EDA9DB4C04C6

Q28750802-401E691F-B572-44EE-98E6-D8132653E823

P304

Q28750802-5B2B20F5-5AE8-4348-A92E-4991551F03F7

P31

Q28750802-D51C2454-9FF1-42DB-89CE-988DB2E1A1C9

P3181

Q28750802-0E328FFD-21C3-4D1B-814A-1847F52C0378

P356

Q28750802-AB984797-E408-4EA6-A588-92187975E143

P407

Q28750802-DDE4CEEB-6AD7-4236-B8CD-00AC20563D5B

P433

Q28750802-63C661DA-AEB2-4881-BBEE-661431A40FD8

P478

Q28750802-32C9CEED-D43F-4503-8DE8-94A5708BA2E5

P577

Q28750802-8D7310F7-E79F-42A6-B120-4118D95548FB

P5875

Q28750802-1FBE923F-3DF8-46BD-B556-765C61104F82

P698

Q28750802-C489584B-4921-4F28-AAA5-886AA4E20F5B

P921

Q28750802-846E6BF5-A403-47B3-9024-C31416AE8018

P932

Q28750802-72C0CED9-842D-468D-8695-7CD25B3A06CB

P3181

P356

JOURNAL.PONE.0011373

P1433

P1476

Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes

@en

P2093

Amanda Mack

http://www.w3.org/2001/XMLSchema#string

Deepika Rajesh

http://www.w3.org/2001/XMLSchema#string

Elizabeth Rondon

http://www.w3.org/2001/XMLSchema#string

Emile F Nuwaysir

http://www.w3.org/2001/XMLSchema#string

Laura Jo Zitur

http://www.w3.org/2001/XMLSchema#string

Matthew E Brown

http://www.w3.org/2001/XMLSchema#string

Rachel Lewis

http://www.w3.org/2001/XMLSchema#string

Randall D Learish

http://www.w3.org/2001/XMLSchema#string

Xuezhu Feng

http://www.w3.org/2001/XMLSchema#string

P2860

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

Cancer regression in patients after transfer of genetically engineered lymphocytes

Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences

Induced pluripotent stem cell lines derived from human somatic cells

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Embryonic stem cell lines derived from human blastocysts

Immortalization eliminates a roadblock during cellular reprogramming into iPS cells

Human induced pluripotent stem cells free of vector and transgene sequences

A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity

The Ink4/Arf locus is a barrier for iPS cell reprogramming

P304

e11373

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

5039534

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0011373

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45114698

http://www.w3.org/2001/XMLSchema#string

P698

20617191

http://www.w3.org/2001/XMLSchema#string

P921

Human Induced Pluripotent Stem Cells

P932

2894062

http://www.w3.org/2001/XMLSchema#string